The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Clinical trial NCT06928246 · RECRUITING

Trial details

NCT number: NCT06928246
Sponsor: Daniel Kaplan
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2025-07-17
Primary completion: 2026-12-15
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.